CONMED
CNMD • NYSE
CONMED is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Patrick J. Beyer, with a market cap of $1.1B.
CEOPatrick J. Beyer
Next Earnings
Upcoming earnings announcement for CONMED
Date
Wednesday, April 29, 2026 (in 3 weeks)
Timing
After Market Close (4:05 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.82
Revenue Estimate
$310.6M
Earnings History
Past 12 earnings reports for CONMED
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 28, 2026 | Q4 2025 | $1.43Est: $1.32 | +8.3% | $373.2MEst: $366.6M | +1.8% |  10-K |
| Nov 5, 2025 | Q3 2025 | $1.08Est: $1.05 | +2.9% | $337.9MEst: $335.5M | +0.7% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $1.15Est: $1.13 | +1.8% | $342.3MEst: $338.9M | +1.0% | 10-Q |
| Apr 30, 2025 | Q1 2025 | $0.95Est: $0.81 | +17.3% | $321.3MEst: $313.4M | +2.5% | 10-Q |
| Feb 5, 2025 | Q4 2024 | $1.34Est: $1.20 | +11.7% | $345.9MEst: $341.1M | +1.4% | 10-K |
| Oct 30, 2024 | Q3 2024 | $1.05Est: $0.99 | +6.1% | $316.7MEst: $318.1M | -0.4% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.98Est: $0.91 | +7.7% | $332.1MEst: $332.3M | -0.1% | 10-Q |
| Apr 24, 2024 | Q1 2024 | $0.79Est: $0.74 | +6.8% | $312.3MEst: $306.8M | +1.8% | 10-Q |
| Jan 31, 2024 | Q4 2023 | $1.06Est: $1.11 | -4.5% | $327.0MEst: $332.2M | -1.6% | 10-K |
| Oct 25, 2023 | Q3 2023 | $0.90Est: $0.83 | +8.4% | $304.6MEst: $300.9M | +1.2% | 10-Q |
| Jul 26, 2023 | Q2 2023 | $0.83Est: $0.79 | +5.1% | $317.7MEst: $306.1M | +3.8% | — |
| Apr 26, 2023 | Q1 2023 | $0.66Est: $0.60 | +10.0% | $295.5MEst: $266.7M | +10.8% | — |